Lipocalin 2 (LCN2) (Middle Region) Peptid
LCN2
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle Lipocalin 2 (LCN2) Produkte
- Lipocalin 2 (LCN2)
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LIPAPPLSKV PLQQNFQDNQ FQGKWYVVGL AGNAILREDK DPQKMYATIY
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LCN2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Lipocalin 2 (LCN2)
- Hintergrund
-
This gene encodes a protein that belongs to the lipocalin family. Members of this family transport small hydrophobic molecules such as lipids, steroid hormones and retinoids. The protein encoded by this gene is a neutrophil gelatinase-associated lipocalin and plays a role in innate immunity by limiting bacterial growth as a result of sequestering iron-containing siderophores. The presence of this protein in blood and urine is an early biomarker of acute kidney injury. This protein is thought to be be involved in multiple cellular processes, including maintenance of skin homeostasis, and suppression of invasiveness and metastasis. Mice lacking this gene are more susceptible to bacterial infection than wild type mice.
Alias Symbols: p25, 24p3, MSFI, NGAL
Protein Size: 200 - Gen-ID
- 3934
- NCBI Accession
- NP_005555
- UniProt
- X6R8F3
-
Sie sind hier:
